Abstract shapes animated in a loop.
Professor John F. Marshall
Meet John, a co-investigator on Rosetta
Professor John Marshall joined the Imperial Cancer Research Fund laboratories in London in 1984. After studying photodynamic therapy, he began his PhD studies on the role of integrins in melanoma, before turning to the study of carcinoma integrins. In 2004, he moved to Barts Cancer Institute in London, since then he has published over 30 papers on avb6 showing that it represents a major target for imaging and therapy of multiple types of carcinoma. He developed an imaging agent for avb6 developed from foot-and-mouth-disease virus which is being used for human PET imaging studies and has co-developed a human avb6-blocking antibody with AstraZeneca-Medimmune.
In the Grand Challenge, the Marshall group will deliver the imaging CyTOF analysis.